Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,304.10 +165.95 1.10%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,230.40 +49.63 0.96%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Cardiome Pharma Corp

+ Add to Watchlist

CRME:US

2.1500 USD 0.0300 1.42%

As of 20:10:00 ET on 05/17/2013.

Company Profile for Cardiome Pharma Corp (CRME)

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with clinical drug programs. The Company's programs focus on atrial arrhythmia and congestive heart failure.

Contact Information

Cardiome Pharma Corp

6190 Agronomy Road
6th Floor
Vancouver, BC V6T 1Z3
Canada
Phone: 1-604-677-6905
Fax: 1-604-677-6915

Key Executives for Cardiome Pharma Corp (CRME)

William L Hunter "Bill"President/CEOJennifer ArchibaldChief Financial Officer
Sheila M GrantChief Operating OfficerDonald A McAfee "Don"Chief Scientific Officer
Karim LaljiChief Commercial OfficerPeter K HofmanSenior Dir:Investor Relations
Joseph GarciaSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil